SAVA
FILANA THERAPEUTICS, INC.
Key Financials
Operating Income
$-95390000
↑ 32.6%
Revenue
$41.1M
0.0%
Net Income
$-90973000
↓ 273.7%
EPS (Diluted)
$-1.88
↓ 28.8%
Total Assets
$118.4M
↓ 24.9%
Cash & Equivalents
$95.5M
↓ 25.7%
Total Liabilities
$44.0M
↑ 271.6%
Shareholders' Equity
$74.4M
↓ 48.9%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 10-K | 3/12/2026 | View on SEC |
| 8-K | 3/12/2026 | View on SEC |
| 8-K | 3/10/2026 | View on SEC |
| 8-K | 2/19/2026 | View on SEC |
| 8-K | 12/23/2025 | View on SEC |
| 8-K/A | 12/22/2025 | View on SEC |
| 8-K | 12/18/2025 | View on SEC |
| 8-K | 12/17/2025 | View on SEC |
| EFFECT | 12/5/2025 | View on SEC |
| 424B2 | 12/5/2025 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | SAVA |
| Company Name | FILANA THERAPEUTICS, INC. |
| CIK | 1069530 |
| Sector | Pharmaceutical Preparations |
| Industry | Non-accelerated filer Smaller reporting company |
| Exchange | Nasdaq |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 512-501-2444 |